Client: Pfizer, New York, NY

Disease Awareness (unbranded): Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

​

ATTR-CM, which is often undiagnosed as its symptoms can mimic common causes of heart failure. ATTR-CM can also include a mix of seemingly unrelated symptoms like digestive problems, pain in the lower back or legs, and an irregular heartbeat. The diagnosis of ATTR-CM globally was estimated at less than 1%, traditionally via an expensive and invasive heart biopsy.

​

To increase awareness and detection rates, Pfizer launched the Suspect and Detect campaign to help doctors recognize the signs and symptoms, and learn about the tools on how to help them diagnose ATTR-CM.